Your browser doesn't support javascript.
loading
Status of ghrelin as an islet hormone and paracrine/autocrine regulator of insulin secretion.
Dezaki, Katsuya; Yada, Toshihiko.
Afiliação
  • Dezaki K; Iryo Sosei University, Faculty of Pharmacy, 5-5-1, Chuodai Iino, Iwaki, Fukushima, 970-8551, Japan. Electronic address: dezaki.katsuya@isu.ac.jp.
  • Yada T; Kansai Electric Power Medical Research Institute, Center for Integrative Physiology, Division of Integrative Physiology, 1-5-6 Minatojimaminamimachi, Chuo-ku, Kobe, 650-0047, Japan; Division of Diabetes, Metabolism and Endocrinology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan. Electronic address: toshihiko.yada@kepmri.org.
Peptides ; 148: 170681, 2022 02.
Article em En | MEDLINE | ID: mdl-34728253
Ghrelin is expressed in the pancreatic islet cells as well as the stomach. In the perfused pancreas and isolated islets, GHS-R antagonism, ghrelin immunoneutralization and ghrelin-knockout (Ghr-KO) all increase glucose-induced insulin release. Thus, pharmacological, immunological and genetic blockades of ghrelin in the pancreatic islets all markedly augment glucose-induced insulin release, showing that islet-derived ghrelin physiologically restricts insulin release in rodents. In this review, we focus on the current understanding of the following key questions: 1) from which islet cells ghrelin is released, 2) on which islet cells ghrelin acts, and 3) mechanisms by which the islet-derived ghrelin inhibits insulin secretion.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ilhotas Pancreáticas / Grelina / Secreção de Insulina Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ilhotas Pancreáticas / Grelina / Secreção de Insulina Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article